Gainers at Biotech: Alcobra (NASDAQ:ADHD), Aratana Therapeutics (NASDAQ:PETX), Northwest Biotherapeutics (NASDAQ:NWBO), Agenus Inc (NASDAQ:AGEN), AEterna Zentaris (NASDAQ:AEZS)

Research analysts at WBB Securities initiated coverage on shares of Alcobra Ltd (NASDAQ:ADHD) in a report released on Thursday, 26 June 2014. The firm set a “hold” rating and a $18.00 price target on the stock. WBB Securities’ target price points to a potential upside of 5.76% from the company’s current price. Alcobra Ltd (NASDAQ:ADHD) stock performance was 5.85% in last session and finished the … Continue reading Gainers at Biotech: Alcobra (NASDAQ:ADHD), Aratana Therapeutics (NASDAQ:PETX), Northwest Biotherapeutics (NASDAQ:NWBO), Agenus Inc (NASDAQ:AGEN), AEterna Zentaris (NASDAQ:AEZS)

Jayne Crisman07/0307/03

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Spirits maker Diageo North America and pharmaceutical giant Pfizer Inc. (NYSE:PFE) have each agreed to pay a $5,000 fine because their lobbyists failed to disclose expenditures for receptions at the 2012 Democratic National Convention, the Office of State Ethics announced. Pfizer Inc. (NYSE:PFE) stock performance was 1.35% in last session and finished the day at $30.08. Traded volume was 25.60million shares in the last session … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Agenus (NASDAQ:AGEN), Merck & Co (NYSE:MRK)

Kristen Barton07/0207/02

Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Zalicus Inc (NASDAQ:ZLCS) on June 18 announced that it has licensed its Sodium Channel Modulator program, including intellectual property and related pipeline assets, to AnaBios Corporation in exchange for clinical milestone payments and royalties on potential future sales. Under the terms of the agreement Zalicus will be eligible to receive up to $17.2 million in clinical and regulatory milestone payments and up to 12% of … Continue reading Biotech Bearish Stocks: Zalicus Inc (NASDAQ:ZLCS), Stemline Therapeutics Inc (NASDAQ:STML), Agenus Inc (NASDAQ:AGEN), Arrowhead Research Corp (NASDAQ:ARWR), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

Kevin Long06/2006/20

Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Agenus Inc. (NASDAQ:AGEN) will release its fourth quarter and year end 2013 financial results before the market opens on March 5, 2014. Agenus Inc. (NASDAQ:AGEN) stock performance was 0.00% in last session and finished the day at $4.89. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 1.12 million shares. The beta of the stock remained 1.33. … Continue reading Biotech Overbought Stocks: Agenus Inc. (NASDAQ:AGEN), Biota Pharmaceuticals (NASDAQ:BOTA), Albany Molecular Research (NASDAQ:AMRI), Sunesis Pharmaceuticals (NASDAQ:SNSS)

Jayne Crisman03/0303/03

Hot News: 3D Systems Corporation (NYSE:DDD), Rite Aid Corporation (NYSE:RAD), Hanesbrands Inc. (NYSE:HBI), Agenus Inc. (NASDAQ:AGEN), SunEdison, Inc. (NYSE:SUNE)

3D Systems Corporation (NYSE:DDD) recently reported that it has signed a definitive agreement to acquire one of the leading CAD/CAM software solutions providers, Cimatron Ltd. (CIMT). The news was received warmly by investors as the stock rose nearly 6.7% in yesterday’s session. The transaction, valued at about $97 million or $8.97 per Cimatron’s share, is likely to be closed by the first quarter of 2015. … Continue reading Hot News: 3D Systems Corporation (NYSE:DDD), Rite Aid Corporation (NYSE:RAD), Hanesbrands Inc. (NYSE:HBI), Agenus Inc. (NASDAQ:AGEN), SunEdison, Inc. (NYSE:SUNE)

Kevin Long11/26